|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Kala Pharmaceuticals (NASDAQ: KALA) through any online brokerage.
The latest price target for Kala Pharmaceuticals (NASDAQ: KALA) was reported by HC Wainwright & Co. on August 6, 2021. The analyst firm set a price target for 11.00 expecting KALA to rise to within 12 months (a possible 494.59% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Kala Pharmaceuticals (NASDAQ: KALA) is $1.85 last updated Fri Nov 26 2021 18:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kala Pharmaceuticals.
Kala Pharmaceuticals’s $Q4 earnings are confirmed for after-market on February 24, 2022.
There is no upcoming split for Kala Pharmaceuticals.
Kala Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.